COSTA MESA, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Sipp Industries, Inc. (OTC:SIPC), a leading player in the cannabis and hemp industries, announces its strategic acquisition of revenue share in Calypso Pharmaceuticals, a Texas-based company renowned for its innovative products and proprietary technology in the cannabis and hemp sectors. The acquisition marks a significant milestone in SIPP Industries' mission to expand its product portfolio and market presence.
Calypso Pharmaceuticals specializes in developing niche products such as beverages, nasal sprays, edibles, topicals, and water-soluble nano-emulsified products tailored for the cannabis and hemp markets. With a focus on enhancing bioavailability, Calypso's proprietary technology achieves an impressive 95% bioavailability, surpassing conventional isolate or distillate-infused products. This breakthrough positions Calypso Pharmaceuticals as a game-changer in product formulation and delivery within the industry.
Calypso Pharmaceuticals operates a robust manufacturing facility in Texas, with plans to launch a new retail storefront in the summer of 2024. Additionally, the company operates a 2,000 square feet manufacturing facility in Oklahoma City, strategically positioned to serve the Oklahoma medical marijuana market and the broader hemp market across the United ...